295 results
Page 4 of 15
8-K
EX-99.1
b5klshoy1etj
31 Dec 15
BioTime Completes Distribution of Approximately 4.75 Million Shares of OncoCyte Corporation Common Stock
12:00am
424B5
hdiin e19zns8aq
14 Sep 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
l034uvaajodcg5q92g0b
24 Feb 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ucopz6p 8ucd
26 Jan 15
BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy
12:00am
8-K
EX-99.1
h0mv3p0
12 Jan 15
BioTime Subsidiary OncoCyte Corporation Appoints William Annett to Its Board of Directors
12:00am
8-K
EX-99.1
h03z9z102vnyep
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
55o0 kbw987m0394
15 Dec 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
7yxn0
15 Dec 14
BioTime Appoints Angus C. Russell to Board of Directors
12:00am
DEFA14A
il38sx7tq0j4z8zs0xn8
14 Oct 14
Additional proxy soliciting materials
12:00am
424B5
mdvtkwujws hjj7
3 Oct 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
vefn1p
25 Sep 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
quw923v 7nzekzk
10 Sep 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
s4zr4m7cf7dy4aagjf
28 Aug 14
BioTime to Collaborate With the University of Wisconsin and Louvain University in Test of HyStem®-Based Hydrogel for Vocal Fold Scarring
12:00am
424B3
hkkeqd55hl4744v
11 Jun 14
Prospectus supplement
12:00am